Stocks · News reference
Analysts upgraded Microsoft, Graphic Packaging, Editas Medicine and Lakefront Biotherapeutics, with mixed price-target changes.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securitize, Lakefront and others also gained.
Guggenheim analyst Debjit Chattopadhyay upgrades Editas Medicine (NASDAQ:EDIT) from Neutral to Buy and announces $5 price target.
JP Morgan analyst Detlef Winckelmann upgrades Graphic Packaging Holding (NYSE:GPK) from Neutral to Overweight and lowers the price target from $12.5 to $11.5.
RBC Capital analyst Brian Abrahams upgrades Lakefront Biotherapeutics (NASDAQ:LKFT) from Sector Perform to Outperform and raises the price target from $26 to $45.
https://blogs.microsoft.com/on-the-issues/2026/09/23/microsoft-strengthens-its-commitment-to-the-middle-east-by-investing-in-technology-digital-resilience-and-people/
Quantum Computing Breakthrough Please click here for an enlarged chart of IONQ Inc (NYSE:IONQ). Note the following: This article is about the big picture, not an individual stock. The chart of IONQ is